PL2581097T3 - Kompozycje do zapobiegania zrostom i innych zastosowań barierowych - Google Patents

Kompozycje do zapobiegania zrostom i innych zastosowań barierowych

Info

Publication number
PL2581097T3
PL2581097T3 PL12196176T PL12196176T PL2581097T3 PL 2581097 T3 PL2581097 T3 PL 2581097T3 PL 12196176 T PL12196176 T PL 12196176T PL 12196176 T PL12196176 T PL 12196176T PL 2581097 T3 PL2581097 T3 PL 2581097T3
Authority
PL
Poland
Prior art keywords
adhesions
prevention
compositions
barrier applications
barrier
Prior art date
Application number
PL12196176T
Other languages
English (en)
Inventor
Rutledge Ellis-Behnke
Terrence W Norchi
Stephen Richard Kelly
Original Assignee
Arch Biosurgery, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39620203&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2581097(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Arch Biosurgery, Inc. filed Critical Arch Biosurgery, Inc.
Publication of PL2581097T3 publication Critical patent/PL2581097T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12196176T 2007-04-25 2008-04-25 Kompozycje do zapobiegania zrostom i innych zastosowań barierowych PL2581097T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/740,284 US9162005B2 (en) 2005-04-25 2007-04-25 Compositions for prevention of adhesions and other barrier applications
EP12196176.7A EP2581097B1 (en) 2007-04-25 2008-04-25 Compositions for prevention of adhesions and other barrier applications

Publications (1)

Publication Number Publication Date
PL2581097T3 true PL2581097T3 (pl) 2017-11-30

Family

ID=39620203

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12196176T PL2581097T3 (pl) 2007-04-25 2008-04-25 Kompozycje do zapobiegania zrostom i innych zastosowań barierowych

Country Status (9)

Country Link
US (3) US9162005B2 (pl)
EP (2) EP2581097B1 (pl)
JP (3) JP5976272B2 (pl)
CA (1) CA2722465C (pl)
DK (1) DK2581097T3 (pl)
ES (1) ES2639625T3 (pl)
HU (1) HUE034194T2 (pl)
PL (1) PL2581097T3 (pl)
WO (1) WO2008134544A1 (pl)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3031466B1 (en) * 2004-07-06 2018-11-28 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
KR20100102750A (ko) * 2005-04-25 2010-09-24 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법
US9877921B2 (en) * 2005-09-09 2018-01-30 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
US20160045457A1 (en) 2005-09-09 2016-02-18 Ousama Rachid Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine
DK1994155T4 (da) 2006-02-13 2022-07-25 Daiichi Sankyo Co Ltd Polynukleotid- og polypeptidsekvenser involveret i fremgangsmåden med knogleremodellering
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
ES2673947T3 (es) * 2006-04-25 2018-06-26 Massachusetts Institute Of Technology Composiciones y métodos para afectar al movimiento de contaminantes, líquidos corporales u otras entidades y/o afectar a otras condiciones fisiológicas
EP2146733B1 (en) * 2007-03-14 2020-11-25 Arch Biosurgery, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
US7906478B2 (en) * 2007-07-20 2011-03-15 The Procter & Gamble Company Personal-care articles having self-assembling peptides
WO2009067711A2 (en) 2007-11-21 2009-05-28 T.J. Smith & Nephew, Limited Suction device and dressing
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
MX2010005552A (es) 2007-11-21 2010-06-02 Smith & Nephew Aposito para heridas.
US20110002880A1 (en) * 2007-12-05 2011-01-06 3-D Matrix, Ltd. Material For Wound Healing and Skin Reconstruction
GB0723875D0 (en) 2007-12-06 2008-01-16 Smith & Nephew Wound management
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
GB0803564D0 (en) 2008-02-27 2008-04-02 Smith & Nephew Fluid collection
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
US9023376B2 (en) * 2008-06-27 2015-05-05 The University Of Akron Nanofiber-reinforced composition for application to surgical wounds
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
WO2010041636A1 (ja) * 2008-10-06 2010-04-15 株式会社スリー・ディー・マトリックス 組織閉塞剤
WO2011072482A1 (en) 2009-12-14 2011-06-23 The University Of Hong Kong Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells
US20120322884A1 (en) 2010-03-01 2012-12-20 University Of Manitoba Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
GB201011173D0 (en) 2010-07-02 2010-08-18 Smith & Nephew Provision of wound filler
JP2013538864A (ja) * 2010-10-08 2013-10-17 ソルヴェイ（ソシエテ アノニム） 生物活性アミノ酸配列及びその使用
GB201020005D0 (en) 2010-11-25 2011-01-12 Smith & Nephew Composition 1-1
WO2012069794A1 (en) 2010-11-25 2012-05-31 Smith & Nephew Plc Composition i-ii and products and uses thereof
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
WO2012078784A1 (en) 2010-12-08 2012-06-14 Convatec Technologies Inc. Wound exudate system accessory
US10207031B2 (en) 2010-12-08 2019-02-19 Convatec Technologies Inc. Integrated system for assessing wound exudates
US8546338B2 (en) 2010-12-08 2013-10-01 Johnson & Johnson Consumer Companies, Inc. Self-assembling hydrogels based on dicephalic peptide amphiphiles
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
CA2853084C (en) * 2011-10-21 2022-04-26 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
WO2013071049A1 (en) * 2011-11-10 2013-05-16 Trustees Of Boston College Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
GB201120693D0 (en) 2011-12-01 2012-01-11 Convatec Technologies Inc Wound dressing for use in vacuum therapy
KR101345333B1 (ko) * 2011-12-30 2013-12-30 조선대학교산학협력단 라이신 및 트립토판 잔기가 ４번 반복된 신규한 항균 및 항진균 펩타이드 및 이의 용도
CA3169368A1 (en) 2012-06-15 2014-01-09 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
EP3466964A1 (en) 2012-07-06 2019-04-10 3-D Matrix Ltd. Fill-finish process for peptide solutions
AU2013293062A1 (en) 2012-07-19 2014-07-24 Alethia Biotherapeutics Inc. Anti-Siglec-15 antibodies
WO2014027042A2 (en) 2012-08-17 2014-02-20 Amsilk Gmbh Use of self-assembling polypeptides as tissue adhesives
EP2935688A2 (en) 2012-12-20 2015-10-28 ConvaTec Technologies Inc. Processing of chemically modified cellulosic fibres
CN105339020B (zh) * 2013-03-14 2020-06-16 立美基股份有限公司 预防胃肠梗阻的材料
US20160120706A1 (en) 2013-03-15 2016-05-05 Smith & Nephew Plc Wound dressing sealant and use thereof
ES2882530T3 (es) 2013-03-22 2021-12-02 Univ Nova Southeastern Partículas finas de epinefrina y métodos para uso de las mismas para el tratamiento de condiciones que responden a la epinefrina
DE102013211316A1 (de) * 2013-06-17 2014-12-18 Aesculap Ag Hämostyptikum
JP6502352B2 (ja) 2013-08-22 2019-04-17 アーチ・バイオサージェリー・インコーポレイテッド 流体の移動を制御するための移植可能なメッシュ
US10245299B2 (en) 2014-03-10 2019-04-02 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
WO2015136370A2 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
WO2015138514A1 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Self-assembling peptide compositions
WO2017106460A1 (en) * 2015-12-15 2017-06-22 3-D Matrix, Ltd. Self-assembling peptides comprising non-ionic polar amino acids for anti-adhesion
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
AU2017232540A1 (en) * 2016-03-18 2018-09-27 3-D Matrix, Ltd. Preventing biological tissue adhesion
MX2018011201A (es) * 2016-03-18 2018-11-22 3 D Matrix Ltd Oclusion de fuga de liquido cefalorraquideo.
JP2019513238A (ja) 2016-03-30 2019-05-23 クオリザイム・ダイアグノスティクス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフトＱｕａｌｉｚｙｍｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｇｍｂｈ Ａｎｄ Ｃｏ． Ｋｇ 創傷における微生物感染の検出
UY37178A (es) 2016-03-30 2017-10-31 Convatec Technologies Inc Detección de infección microbiana en heridas
WO2018005427A1 (en) * 2016-06-27 2018-01-04 3-D Matrix, Ltd. Self-assembling peptide matrix for the prevention of esophageal stricture after endoscopic dissection
AU2017292876B2 (en) 2016-07-08 2022-01-20 Convatec Technologies Inc. Fluid collection apparatus
EP3871645B1 (en) 2016-07-08 2022-05-04 ConvaTec Technologies Inc. Flexible negative pressure system
AU2017292028B2 (en) 2016-07-08 2023-03-02 Convatec Technologies Inc. Fluid flow sensing
WO2019089856A1 (en) 2017-10-31 2019-05-09 InMEDBio, LLC Absorbent, breathable and pathogen blocking/killing wound care dressing and fabrication thereof
US11324703B2 (en) 2017-12-15 2022-05-10 3-D Matrix, Ltd. Surfactant peptide nanostructures and uses thereof in drug delivery
WO2019182905A1 (en) 2018-03-23 2019-09-26 Arch Biosurgery, Inc. Sap and peptidomimetics for treatment of eye disease
CN112165952A (zh) * 2018-03-23 2021-01-01 阿奇生物外科有限公司 用于减轻炎症症状的sap和拟肽组合物
US20210220429A1 (en) * 2018-10-05 2021-07-22 Kurume University Pharmaceutical composition for treating or preventing ulcer or fistula in intestinal tract
CN109513044B (zh) * 2019-01-29 2022-02-18 北京颢美细胞基因生物技术有限公司 用于微整形的再生组织基质微粒植入剂、制备方法及应用
CN113661427A (zh) * 2019-04-09 2021-11-16 富士胶片株式会社 内窥镜用交联体、内窥镜以及用于形成内窥镜用交联体的组合物
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems
EP4090350A1 (en) 2020-01-13 2022-11-23 Arch Biosurgery, Inc. Self-assembling peptide gel formulation and methods of use
WO2023108026A2 (en) 2021-12-08 2023-06-15 Oakgrove Bio Llc Biological production of histidine-rich peptides
CN116789854B (zh) * 2023-06-08 2024-04-02 东北农业大学 兼具细菌捕获与抑菌功能的纳米抗菌肽及制备方法和应用

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4098728A (en) 1976-01-02 1978-07-04 Solomon Rosenblatt Medical surgical sponge and method of making same
US4211227A (en) 1978-07-03 1980-07-08 The Kendall Company Surgical sponge material
US4272398A (en) 1978-08-17 1981-06-09 The United States Of America As Represented By The Secretary Of Agriculture Microencapsulation process
US4636208A (en) 1984-10-05 1987-01-13 Ewald Rath Surgical sponge
US4829000A (en) 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
US4861627A (en) 1987-05-01 1989-08-29 Massachusetts Institute Of Technology Preparation of multiwall polymeric microcapsules
US5019646A (en) 1987-08-25 1991-05-28 Regents Of The University Of Minnesota Polypeptides with fibronectin activity
US5843156A (en) 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
CA2122041A1 (en) 1989-12-04 1993-04-29 Kenneth Kensey Plug device for sealing openings and method of use
US5180375A (en) 1991-05-02 1993-01-19 Feibus Miriam H Woven surgical drain and woven surgical sponge
US5222974A (en) 1991-11-08 1993-06-29 Kensey Nash Corporation Hemostatic puncture closure system and method of use
US5955343A (en) * 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5645565A (en) 1995-06-13 1997-07-08 Ethicon Endo-Surgery, Inc. Surgical plug
US5762846A (en) 1996-12-20 1998-06-09 E. I. Du Pont De Nemours And Company Dispersion spinning process for polytetrafluoroethylene and related polymers
US6368877B1 (en) 1997-06-25 2002-04-09 Massachusetts Institute Of Technology Self-assembling peptide surfaces for cell patterning and interactions
US5956343A (en) 1997-12-23 1999-09-21 Alcatel Usa Sourcing L.P. Designating a control channel in a telecommunications system
US6235340B1 (en) 1998-04-10 2001-05-22 Massachusetts Institute Of Technology Biopolymer-resistant coatings
WO2000041732A1 (en) 1999-01-19 2000-07-20 The Children's Hospital Of Philadelphia Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
WO2000063079A1 (en) 1999-04-15 2000-10-26 Ultracell Medical Technologies Of Connecticut, Inc. Method for producing surgical sponge device and product thereof
US6844324B1 (en) 1999-11-12 2005-01-18 Massachusetts Institute Of Technology Modular peptide mediated intracellular delivery system and uses therefore
US6953659B2 (en) 2000-07-14 2005-10-11 Massachusetts Institute Of Technology Direct, externally imposed control of nucleic acids
US6953656B2 (en) 2000-07-14 2005-10-11 Massachusetts Institute Of Technology Direct, externally imposed control of polypeptides
US6846319B2 (en) 2000-12-14 2005-01-25 Core Medical, Inc. Devices for sealing openings through tissue and apparatus and methods for delivering them
ES2325531T3 (es) * 2001-01-31 2009-09-08 Asahi Glass Company, Limited Proceso para producir un compuesto de fluor.
ATE419333T1 (de) 2001-02-06 2009-01-15 Massachusetts Inst Technology Peptidgerüstverkapselung von gewebszellen und verwendungen davon
US7449180B2 (en) 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
MXPA03010103A (es) * 2001-05-04 2004-03-10 Scripps Research Inst Peptidos y composiciones anti-microbianos.
US7179784B2 (en) 2001-07-10 2007-02-20 Massachusetts Institute Of Technology Surfactant peptide nanostructures, and uses thereof
WO2003052117A2 (en) 2001-09-19 2003-06-26 Massachusetts Institute Of Technology Methods and products related to non-viral transfection
AU2003222167A1 (en) 2002-04-02 2003-10-20 Northwestern University Peptide amphiphile solutions and self assembled peptide nanofiber networks
AU2003249606A1 (en) 2002-05-13 2003-12-02 Massachusetts Institute Of Technology Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
CA2387257C (en) 2002-05-23 2009-07-28 Suncor Energy Inc. Static deaeration conditioner for processing of bitumen froth
GB0216286D0 (en) 2002-07-15 2002-08-21 Univ Leeds Network
EP1542709A2 (en) 2002-08-06 2005-06-22 EPIX Pharmaceuticals, Inc. Peptide aggregates
KR20050100397A (ko) 2003-02-11 2005-10-18 노오쓰웨스턴 유니버시티 나노결정질 표면 코팅을 위한 방법 및 물질, 및 이의상부로의 펩티드 양친매성 나노섬유의 부착
WO2004110964A2 (en) * 2003-06-16 2004-12-23 Nuevolution A/S Encoded molecules by translation (emt)
US7713923B2 (en) * 2003-06-25 2010-05-11 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
EP1636250B1 (en) 2003-06-25 2016-01-06 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and uses thereof
US7846891B2 (en) 2003-10-17 2010-12-07 Massachusetts Institute Of Technology Self-assembling peptides for regeneration and repair of neural tissue
US7704740B2 (en) 2003-11-05 2010-04-27 Michigan State University Nanofibrillar structure and applications including cell and tissue culture
EP1696945B1 (en) * 2003-12-05 2012-01-18 Northwestern University Self-assembling peptide amphiphiles and related methods for growth factor delivery
GB0413346D0 (en) 2004-06-15 2004-07-21 Theryte Ltd Treating cancer
EP3031466B1 (en) 2004-07-06 2018-11-28 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US7884185B2 (en) 2004-07-28 2011-02-08 University Of Delaware Hydrogels and uses thereof
EP1781310B1 (en) 2004-08-02 2015-10-14 Ramot at Tel Aviv University Ltd. Articles of peptide nanostructures and method of forming the same
US8039258B2 (en) 2004-09-28 2011-10-18 Ethicon, Inc. Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
US7399831B2 (en) 2004-10-25 2008-07-15 The Brigham And Women's Hospital, Inc. Targeted delivery of biological factors using self-assembling peptide nanofibers
CA2592292A1 (en) 2005-01-04 2006-07-13 The Brigham And Women's Hospital, Inc. Sustained delivery of pdgf using self-assembling peptide nanofibers
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
KR20100102750A (ko) * 2005-04-25 2010-09-24 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법
US8420605B2 (en) 2005-09-07 2013-04-16 The University Of Strathclyde Hydrogel compositions
ES2673947T3 (es) 2006-04-25 2018-06-26 Massachusetts Institute Of Technology Composiciones y métodos para afectar al movimiento de contaminantes, líquidos corporales u otras entidades y/o afectar a otras condiciones fisiológicas
US20070287741A1 (en) * 2006-06-13 2007-12-13 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
WO2007147002A2 (en) * 2006-06-13 2007-12-21 Wisconsin Alumni Research Foundation Beta-peptide lyotropic liquid crystals and methods of manufacture and use thereof
EP2146733B1 (en) 2007-03-14 2020-11-25 Arch Biosurgery, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
US20110002880A1 (en) 2007-12-05 2011-01-06 3-D Matrix, Ltd. Material For Wound Healing and Skin Reconstruction
WO2010041636A1 (ja) 2008-10-06 2010-04-15 株式会社スリー・ディー・マトリックス 組織閉塞剤
US8512728B2 (en) 2009-02-21 2013-08-20 Sofradim Production Method of forming a medical device on biological tissue
US20120085262A1 (en) 2010-08-26 2012-04-12 Freudenberg Forschungsdienste Kg Production of Highly Concentrated Solutions of Self-Assembling Proteins
TW201315479A (zh) 2011-10-12 2013-04-16 Univ Nat Cheng Kung 可促進動脈新生之醫藥組成物、及其製備方法與應用
WO2014014613A2 (en) 2012-06-20 2014-01-23 President And Fellows Of Harvard College Self-assembling peptides, peptide nanostructures and uses thereof
US9120841B2 (en) 2012-09-28 2015-09-01 Agency For Science, Technology And Research Amphiphilic linear peptidepeptoid and hydrogel comprising the same
JP6502352B2 (ja) 2013-08-22 2019-04-17 アーチ・バイオサージェリー・インコーポレイテッド 流体の移動を制御するための移植可能なメッシュ

Also Published As

Publication number Publication date
EP2150268A1 (en) 2010-02-10
JP6113764B2 (ja) 2017-04-12
JP2015128593A (ja) 2015-07-16
JP6441978B2 (ja) 2018-12-19
JP5976272B2 (ja) 2016-08-23
JP2010526779A (ja) 2010-08-05
ES2639625T3 (es) 2017-10-27
HUE034194T2 (en) 2018-02-28
CA2722465A1 (en) 2008-11-06
US20180008666A1 (en) 2018-01-11
CA2722465C (en) 2017-10-31
JP2017159044A (ja) 2017-09-14
WO2008134544A1 (en) 2008-11-06
US20080032934A1 (en) 2008-02-07
US9789157B2 (en) 2017-10-17
US20160030505A1 (en) 2016-02-04
US10682386B2 (en) 2020-06-16
EP2581097A1 (en) 2013-04-17
US9162005B2 (en) 2015-10-20
EP2581097B1 (en) 2017-06-07
DK2581097T3 (en) 2017-08-07

Similar Documents

Publication Publication Date Title
PL2581097T3 (pl) Kompozycje do zapobiegania zrostom i innych zastosowań barierowych
EP2010117A4 (en) COMPOSITIONS AND METHODS FOR ADHESION INHIBITION
HK1207594A1 (en) Compositions and methods for the prevention and treatment of autoimmune conditions
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
EP2219554A4 (en) PROGESTER-CONTAINING COMPOSITIONS AND DEVICES
EP2162004A4 (en) ANTIMICROBIAL COMPOSITIONS AND USES THEREOF
EP2056835A4 (en) PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
IL200885A (en) A history of mannich-based compounds and pharmacological preparations including them
IL203329A (en) Compounds and their use in the manufacture of anti-fibrosis drugs
IL247086A0 (en) Nitrogen-containing compounds and pharmaceutical preparations
EP2182810A4 (en) COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING OSTEOARTHRITIS
ZA201002181B (en) Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
HK1215037A1 (zh) 流感抑制組合物和方法
EP2079784A4 (en) SEALING ARTICLES AND COMPOSITIONS USEFUL THEREIN
EP2104554A4 (en) particle compositions
EP2320729A4 (en) GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FROM THEREOF
HK1162483A1 (zh) 抑制激酶通路的組合物和方法
ZA201005442B (en) Pharmaceutical compositions of amlodipine and valsartan
GB0608126D0 (en) Barrier compositions
HK1139153A1 (en) Quinolone compound and pharmaceutical composition
EP2361087A4 (en) INFLAMMATORY COMPOUNDS AND COMPOSITIONS THEREFOR
ZA201002182B (en) Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
EP2056830A4 (en) SPECIAL COMPOSITIONS FOR TREATMENT OR PREVENTION OF METABOLIC SYNDROME
GB0902648D0 (en) Pharmaceutical compounds and compositions
GB0701170D0 (en) Compositions and uses thereof